Search

everythinglearnresearchcommunity

for

Search:↓

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

Removing a methyl group from the ITGAV gene speeds up bone formation in a specific type of bone disease model.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

TGF-alpha is present in sheep and ferret skin and may affect hair growth without directly stimulating cell proliferation.

Injecting triamcinolone into the eyebrow area may help eyelash regrowth in alopecia areata patients.

A fungal infection was successfully treated with oral and topical antifungals after being misdiagnosed and worsened by corticosteroids.

Combining CGF and microneedling with betamethasone effectively treats resistant alopecia areata.

A multi-drug treatment can effectively clear extensive calcinosis in juvenile dermatomyositis.

An 11-year-old girl's hair regrew after treating her thyroid condition with carbimazole.

The skin can independently form immune responses through special structures, offering new ways to treat skin diseases.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Epidermoid cysts can be better diagnosed with ultrasound by recognizing specific features and using clinical information.

A sugar glider had a rare skin cancer that worsened despite treatment, highlighting the need for thorough checks in exotic pets.

Some brain cancer cells avoid immune system detection, and certain treatments could target this to slow their growth; also, certain fat cell precursors help regenerate hair and skin after injury.

Cyclosporin effectively and safely treated skin diseases in three pets with no side effects.

Enlarged sweat gland ducts may indicate scarring hair loss.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

The cat died from a hard-to-treat fungal infection despite various treatments.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

A kidney transplant patient developed leprosy, likely due to immunosuppression and genetic factors, and improved with treatment.

Betamethasone activates and increases the growth of certain skin cells from hair follicles.

TB can mimic SLE symptoms, so doctors should consider TB in such cases.

Mogamulizumab treatment in Sézary syndrome may cause skin issues and hair loss but can lead to a complete response.

Dermal IgA deposition without symptoms is rare in Dermatitis herpetiformis risk groups.

Special cells can help regrow hair in alopecia areata.

Combined prednisone and cyclosporine therapy led to excellent hair regrowth and improved well-being.

Tacrolimus treatment for autoimmune hepatitis can cause hair loss.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.